Chinese diagnostics specialist Gensky raises $7.12m in Series B+ round

Chinese diagnostics specialist Gensky raises $7.12m in Series B+ round

Genskey launches a new testing kit on January 20 for the detection of infectious diseases, including the latest strain of the coronavirus. Source: Company Website

Genskey, a genetic testing and diagnostics startup, has raised 50 million yuan ($7.12 million) in a Series B+ round of financing led by an affiliate of Shenzhen-based venture capital firm Fortune Capital.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter